Wardwizard Healthcare Board Takes Action on SEBI Insider Trading Regulation Non-Compliance

Wardwizard Healthcare Limited recently convened a board meeting on February 12, 2026, to address concerns related to non-compliance with SEBI insider trading regulations for the quarters ending March 31, 2025, June 30, 2025, and September 30, 2025. The company acknowledged the inadvertent submission of SDD certificates without the required Practicing Company Secretary certification and has since rectified the issue by resubmitting properly certified documents. The board expressed regret for the oversight and vowed to prevent similar compliance lapses in the future.

During the board meeting held on February 12, 2026, the Wardwizard Healthcare Limited board discussed critical compliance issues concerning SEBI’s Insider Trading Regulations. The primary focus was on the company’s failure to comply with SDD (Structured Digital Database) requirements for three consecutive quarters.

The compliance issues were specifically identified for the following quarters: Q4FY25 (ending March 31, 2025), Q1FY26 (ending June 30, 2025), and Q2FY26 (ending September 30, 2025). According to a statement issued by the board, the company was obligated to submit SDD certificates that were duly certified by a Practicing Company Secretary, as outlined in Exchange Circular No. 20241018-44 from October 18, 2024. Unfortunately, the company submitted SDD certificates without the required Practicing Company Secretary certification for all three quarters, an oversight that was acknowledged by the board.

The board expressed genuine regret for this inadvertent error and clarified that it was not a deliberate violation but rather a mistake. To rectify the situation, the company’s secretarial team took immediate corrective action by resubmitting the SDD certificates with the proper Practicing Company Secretary certification on December 1, 2025, with an additional submission made on January 3, 2026, covering all three affected quarters.

In response to these compliance challenges, the Board of Directors underscored the company’s commitment to future compliance by emphasizing the importance of adhering to all regulatory requirements. They assured stakeholders that such oversights would be avoided in the future and pledged to take all necessary steps to ensure strict adherence to applicable rules and regulations. Additionally, the board highlighted its dedication to upholding the highest standards of compliance and maintaining positive relationships with the exchange.

This proactive response by the board exemplifies Wardwizard Healthcare Limited’s commitment to regulatory compliance and corporate governance standards moving forward. It underscores the company’s commitment to rectifying past oversights and implementing measures to prevent similar issues in the future.